Terms: = Lymphoma AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Prognosis
4 results:
1. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
Macauda A; Piredda C; Clay-Gilmour AI; Sainz J; Buda G; Markiewicz M; Barington T; Ziv E; Hildebrandt MAT; Belachew AA; Varkonyi J; Prejzner W; Druzd-Sitek A; Spinelli J; Andersen NF; Hofmann JN; Dudziński M; Martinez-Lopez J; Iskierka-Jazdzewska E; Milne RL; Mazur G; Giles GG; Ebbesen LH; Rymko M; Jamroziak K; Subocz E; Reis RM; Garcia-Sanz R; Suska A; Haastrup EK; Zawirska D; Grzasko N; Vangsted AJ; Dumontet C; Kruszewski M; Dutka M; Camp NJ; Waller RG; Tomczak W; Pelosini M; Raźny M; Marques H; Abildgaard N; Wątek M; Jurczyszyn A; Brown EE; Berndt S; Butrym A; Vachon CM; Norman AD; Slager SL; Gemignani F; Canzian F; Campa D
Int J Cancer; 2021 Jul; 149(2):327-336. PubMed ID: 33675538
[TBL] [Abstract] [Full Text] [Related]
2. Primary colorectal lymphomas: review of the literature.
Dionigi G; Annoni M; Rovera F; Boni L; Villa F; Castano P; Bianchi V; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S169-71. PubMed ID: 18024019
[TBL] [Abstract] [Full Text] [Related]
3. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.
Suguro M; Tagawa H; Kagami Y; Okamoto M; Ohshima K; Shiku H; Morishima Y; Nakamura S; Seto M
Cancer Sci; 2006 Sep; 97(9):868-74. PubMed ID: 16856881
[TBL] [Abstract] [Full Text] [Related]
4. The development and application of imatinib.
Jones RL; Judson IR
Expert Opin Drug Saf; 2005 Mar; 4(2):183-91. PubMed ID: 15794712
[TBL] [Abstract] [Full Text] [Related]
